Arrhythmias, Atrial Fibrillation, Basic Science

 Arrhythmias


Session TitleTitleSpeaker
Moving from cure to palliationEnd of life issues in implantable cardioverter-defibrillator patients.Liu P (Toronto, CA)
Highlight SessionArrhythmias.Vardas P E (Heraklion, GR)

 Atrial Fibrillation


Session TitleTitleSpeaker
Management of atrial fibrillation in the elderlyMedical management of atrial fibrillation: what is different?Raviele A (Mestre, IT)
Management of atrial fibrillation in the elderlyPacemakers and atrioventricular node ablation.Willems R (Leuven, BE)
Management of atrial fibrillation in the elderlyPulmonary vein isolation: for which patients?Kottkamp H (Zurich, CH)
Clinical Trial Update IIAtrial Fibrillation and Congestive Heart Failure (AF-CHF) Trial - Discussant.Maggioni A P (Florence, IT)
State of the Art - Atrial fibrillation ablation: cutting edgeLeft atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation: a prospective randomized study.Tamborero Noguera D (Barcelona, ES)
State of the Art - Atrial fibrillation ablation: cutting edgeCatheter ablation of left atrial ganglionate plexi: long-term results.Pokuschalov E (Novosibirsk, RU)
State of the Art - Atrial fibrillation ablation: cutting edgeUsing 3D delayed-enhancement MRI to identify gap lesions following failed pulmonary vein isolation to help guide repeat radiofrequency ablation in atrial fibrillation patients.Badger TJ (Midvale, US)
State of the Art - Atrial fibrillation ablation: cutting edgeState of the Art - Atrial fibrillation ablation: cutting edge.Brugada Terradellas P (Brussels, BE)
Clinical Trial Update IIIATHENA: The effect of dronedarone on cardiovascular outcomes and stroke in patients with atrial fibrillation.Connolly S J (Hamilton, CA)
Clinical Trial Update IIIATHENA: The effect of dronedarone on cardiovascular outcomes and stroke in patients with atrial fibrillation. - Discussant.Kuck K-H (Hamburg, DE)

 Basic Sciences


Session TitleTitleSpeaker
Science Hot LineLocal atherosclerotic plaque osteopontin is a prognostic biomarker for adverse cardiovascular events in heart, brain and periphery.Pasterkamp G (Utrecht, NL)
Science Hot LineNa+/H+ exchanger 1- and aquaporin-1-dependent hyperosmolary changes decrease nitric oxide production and induce VCAM-1 expression in endothelial cells exposed to high glucose.Madonna R (Chieti, IT)
Science Hot LineOverexpression of VEGF-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.Bry M (Helsinki, FI)
Science Hot LineHigh density lipoprotein (HDL) loses major vasoprotective properties in patients with stable coronary disease and acute coronary syndrome as compared to HDL from healthy subjects - important novel implications for HDL-targeted treatment strategies.Besler C (Zurich, CH)
Science Hot LineIn vivo measurement of regional and local aortic pulse-wave velocity in mice with MRI at 17.6 Tesla.Parczyk M (Wuerzburg, DE)
ESC William Harvey Lecture on Basic ScienceThe immune response in atherosclerosis - cause of inflammation and source of protection.Hansson G K (Stockholm, SE)
Stem cells: what the clinician should knowWhat is a stem cell and what stem cell might be good for the heart?Beeres S L M A (Leiden, NL)
Stem cells: what the clinician should knowConcern about jumping on the bandwagon?Fuster V (New York, US)
ESC Andreas Gruentzig Lecture on Interventional CardiologyHow preclinical biocompatibility studies in various animal models help predict human responses to intravascular devices.R Virmani (Gaithersburg, US)
Highlight SessionBasic ScienceCasadei B (Oxford, GB)